Caleres Reports Lower Q4 Sales, Cautious Outlook For 2025 Amid Inflation And Tariffs

Benzinga
03-20

Caleres, Inc. (NYSE:CAL) shares are trading higher after the company reported fourth-quarter results.

Revenues fell 8.3% year over year to $639.2 million, missing the analyst consensus of $653.86 million.

Famous Footwear sales fell 9.6% Y/Y, with comparable store sales down 2.9%. Brand Portfolio sales decreased 7.2% in the quarter.

“Famous Footwear’s business softened in the quarter, but we maximized key selling periods. We invested to support our long-term growth while continuing to evolve our supply chain and further mitigate the impact of additional tariffs,” said Jay Schmidt, president and chief executive officer.

The company’s gross margin rate contracted 80 basis points year over year to 43.0% and adjusted EBITDA fell to $29.0 million.

Adjusted EPS of 33 cents beat the consensus of 24 cents.

In 2024, Caleres returned $74.7 million in cash to shareholders through dividends and share repurchases. Borrowings under the revolving credit facility totaled $219.5 million at the end of the period.

“As we look forward to 2025 and the macroeconomic environment with persistent inflation and newer tariffs, we believe it is prudent to take a conservative view for the year,” added Schmidt.

Outlook: The company expects FY25 net sales to decline by 1% to up 1% and EPS of $2.80 – $3.20 (consensus $3.21).

For the first quarter, Caleres expects sales to decline 5% – 6% and EPS of $0.35 – $0.40 vs. consensus of $0.87.

Caleres said it currently expects 75% of its Brand Portfolio, and an even greater percentage of Lead Brands’ sourcing to be outside of China by the second half of 2025.

Last month, the company inked a deal to acquire Stuart Weitzman from Tapestry for $105 million. The guidance excludes this acquisition, which is expected to close in the summer of 2025.

Price Action: CAL shares are down 2.46% at $15.99 at the last check Thursday.

Read Next:

  • Temu Parent PDD Holdings Drops After Q4 Revenue Miss: Details

Image via Shutterstock.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10